Magle Group announced the presentation of data from the company's first post-market clinical follow-up study of SmartPAN - an innovative first-in-class medical device developed to improve the outcome of pancreatic surgery. The results were presented at the 140th German Surgery Congress, April 26-28th in Munich. Postoperative pancreatic fistula (POPF) is a common and potentially life-threatening complication that can emerge due to leaking pancreatic fluid after pancreatic surgery.

SmartPAN® acts as an intraoperative indicator of leakage by providing an immediate and accurate color indication when in contact with the pancreatic fluid, guiding the surgeon to perform additional targeted closure. The product offers a completely new, simple approach to preventing pancreatic leaks to benefit patient outcomes.